Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1987 1
1991 1
1996 4
1997 3
1998 3
1999 2
2000 3
2001 4
2002 4
2003 4
2004 9
2005 8
2006 12
2007 9
2008 9
2009 16
2010 12
2011 12
2012 14
2013 16
2014 20
2015 14
2016 14
2017 10
2018 8
2019 6
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Results by year
Filters applied: . Clear all
Page 1
Advances in the diagnosis and treatment of Von Willebrand disease.
Sharma R, Flood VH. Sharma R, et al. Blood. 2017 Nov 30;130(22):2386-2391. doi: 10.1182/blood-2017-05-782029. Blood. 2017. PMID: 29187375 Free PMC article. Review.
Heyde Syndrome: Aortic Stenosis and Beyond.
Blackshear JL. Blackshear JL. Clin Geriatr Med. 2019 Aug;35(3):369-379. doi: 10.1016/j.cger.2019.03.007. Epub 2019 May 27. Clin Geriatr Med. 2019. PMID: 31230737 Review.
von Willebrand Disease: Diagnostic Strategies and Treatment Options.
Ng CJ, Di Paola J. Ng CJ, et al. Pediatr Clin North Am. 2018 Jun;65(3):527-541. doi: 10.1016/j.pcl.2018.02.004. Pediatr Clin North Am. 2018. PMID: 29803281 Review.
Advances in the diagnosis and treatment of Von Willebrand disease.
Sharma R, Flood VH. Sharma R, et al. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):379-384. doi: 10.1182/asheducation-2017.1.379. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222282 Free PMC article. Review.
von Willebrand Disease in Pediatrics: Evaluation and Management.
O'Brien SH, Saini S. O'Brien SH, et al. Hematol Oncol Clin North Am. 2019 Jun;33(3):425-438. doi: 10.1016/j.hoc.2019.01.010. Hematol Oncol Clin North Am. 2019. PMID: 31030811 Review.
State of the art: von Willebrand disease.
James AH, Eikenboom J, Federici AB. James AH, et al. Haemophilia. 2016 Jul;22 Suppl 5:54-9. doi: 10.1111/hae.12984. Haemophilia. 2016. PMID: 27405677 Review.
Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
Franchini M, Mannucci PM. Franchini M, et al. Expert Rev Hematol. 2016 Sep;9(9):825-30. doi: 10.1080/17474086.2016.1214070. Epub 2016 Jul 28. Expert Rev Hematol. 2016. PMID: 27427955 Review.
In addition, a new recombinant VWF has been recently manufactured and licensed in the USA. AREAS COVERED: This narrative review, after a brief presentation of the current therapeutic strategies in VWD, will focus on recombinant VWF, analyzing its characteristics and the re …
In addition, a new recombinant VWF has been recently manufactured and licensed in the USA. AREAS COVERED: This narrative review, afte …
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.
Laffan MA, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling DM. Laffan MA, et al. Br J Haematol. 2014 Nov;167(4):453-65. doi: 10.1111/bjh.13064. Epub 2014 Aug 12. Br J Haematol. 2014. PMID: 25113304 Free PMC article. Review. No abstract available.
197 results
Jump to page
Feedback